Atlas Trials

S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma

Clinical trial NCT00121186 · TERMINATED

Trial details

NCT number
NCT00121186
Sponsor
SWOG Cancer Research Network
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2005-07-01
Primary completion
2008-01-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.